Human CD 133 Positive (CD133+) Liver Cells

Description

Human CD133 Positive (CD133+) Liver Cells are isolated from human liver tissue and purified using magnetic cell sorting technology. These cells are derived from a prenatal developmental stage and may originate from a single donor or be pooled from multiple donors, depending on specific experimental needs. CD133+ liver cells are of particular interest in liver cancer research. These cells are implicated in tumor initiation, metastasis, recurrence, and resistance to chemotherapy. Human CD133+ Liver Cells offer a valuable in vitro model for studying liver development, liver regeneration, and oncogenic pathways. To preserve cell quality and function, repeated freeze-thaw cycles should be avoided during handling and culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.